Portage Biotech (PRTG) Competitors $8.65 +1.63 (+23.22%) Closing price 03:59 PM EasternExtended Trading$8.31 -0.34 (-3.93%) As of 07:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PRTG vs. FBLG, ASBP, LGVN, AYTU, LSTA, NAII, DARE, RVPH, CVKD, and ELEVShould you be buying Portage Biotech stock or one of its competitors? The main competitors of Portage Biotech include FibroBiologics (FBLG), Aspire Biopharma (ASBP), Longeveron (LGVN), Aytu BioPharma (AYTU), Lisata Therapeutics (LSTA), Natural Alternatives International (NAII), Dare Bioscience (DARE), Reviva Pharmaceuticals (RVPH), Cadrenal Therapeutics (CVKD), and Elevation Oncology (ELEV). These companies are all part of the "pharmaceutical products" industry. Portage Biotech vs. Its Competitors FibroBiologics Aspire Biopharma Longeveron Aytu BioPharma Lisata Therapeutics Natural Alternatives International Dare Bioscience Reviva Pharmaceuticals Cadrenal Therapeutics Elevation Oncology Portage Biotech (NASDAQ:PRTG) and FibroBiologics (NASDAQ:FBLG) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, media sentiment, valuation, dividends, profitability, analyst recommendations, institutional ownership and risk. Is PRTG or FBLG more profitable? Portage Biotech's return on equity of 0.00% beat FibroBiologics' return on equity.Company Net Margins Return on Equity Return on Assets Portage BiotechN/A N/A N/A FibroBiologics N/A -710.25%-118.02% Do analysts recommend PRTG or FBLG? FibroBiologics has a consensus price target of $13.00, indicating a potential upside of 2,323.56%. Given FibroBiologics' stronger consensus rating and higher possible upside, analysts plainly believe FibroBiologics is more favorable than Portage Biotech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Portage Biotech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00FibroBiologics 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.20 Which has better earnings and valuation, PRTG or FBLG? FibroBiologics is trading at a lower price-to-earnings ratio than Portage Biotech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPortage BiotechN/AN/A-$6.77M-$41.65-0.21FibroBiologicsN/AN/A-$11.16M-$0.36-1.49 Does the media favor PRTG or FBLG? In the previous week, FibroBiologics had 6 more articles in the media than Portage Biotech. MarketBeat recorded 6 mentions for FibroBiologics and 0 mentions for Portage Biotech. Portage Biotech's average media sentiment score of 0.00 beat FibroBiologics' score of -0.33 indicating that Portage Biotech is being referred to more favorably in the media. Company Overall Sentiment Portage Biotech Neutral FibroBiologics Neutral Which has more risk and volatility, PRTG or FBLG? Portage Biotech has a beta of 0.24, indicating that its share price is 76% less volatile than the S&P 500. Comparatively, FibroBiologics has a beta of -0.74, indicating that its share price is 174% less volatile than the S&P 500. Do insiders and institutionals believe in PRTG or FBLG? 13.4% of Portage Biotech shares are held by institutional investors. 20.8% of FibroBiologics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. SummaryPortage Biotech and FibroBiologics tied by winning 7 of the 14 factors compared between the two stocks. Get Portage Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for PRTG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PRTG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PRTG vs. The Competition Export to ExcelMetricPortage BiotechMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$9.08M$2.96B$5.50B$9.55BDividend YieldN/A2.41%4.71%4.14%P/E Ratio-0.2117.1828.7823.91Price / SalesN/A306.45438.3895.11Price / CashN/A42.6035.6858.35Price / Book-10.958.008.225.62Net Income-$6.77M-$54.52M$3.25B$265.35M7 Day Performance39.52%-0.87%-0.73%-0.89%1 Month Performance47.61%13.63%5.52%4.98%1 Year Performance173.46%11.57%28.79%23.50% Portage Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PRTGPortage BiotechN/A$8.65+23.2%N/A+149.5%$9.08MN/A-0.216Gap UpFBLGFibroBiologics3.2455 of 5 stars$0.60-7.9%$13.00+2,052.3%-85.3%$24.01MN/A-2.8810Earnings ReportAnalyst ForecastASBPAspire BiopharmaN/A$0.48-1.2%N/AN/A$23.55MN/A0.00N/AGap DownLGVNLongeveron2.686 of 5 stars$1.56-4.8%$8.67+455.2%-41.5%$23.52M$2.39M-0.2520News CoveragePositive NewsUpcoming EarningsShort Interest ↑Gap UpAYTUAytu BioPharma3.2003 of 5 stars$2.55-3.2%$10.00+292.9%+1.6%$22.85M$81M-3.53160Gap DownLSTALisata Therapeutics2.3289 of 5 stars$2.64+0.4%$23.50+790.2%-0.3%$22.76M$1M-1.1530Positive NewsUpcoming EarningsNAIINatural Alternatives InternationalN/A$3.65+1.4%N/A-32.3%$22.56M$113.80M-2.63290Positive NewsDAREDare Bioscience1.3883 of 5 stars$2.48-2.7%$12.00+383.9%-25.2%$22.44M$10K-14.6230Upcoming EarningsRVPHReviva Pharmaceuticals2.8802 of 5 stars$0.46-5.7%$9.00+1,848.1%-51.7%$22.27MN/A-0.595Upcoming EarningsShort Interest ↑Gap UpCVKDCadrenal Therapeutics2.32 of 5 stars$11.12-4.0%$32.00+187.9%N/A$21.90MN/A-1.204News CoverageGap UpELEVElevation Oncology2.1613 of 5 stars$0.37flat$3.39+827.6%N/A$21.62MN/A-0.4540 Related Companies and Tools Related Companies FibroBiologics Alternatives Aspire Biopharma Alternatives Longeveron Alternatives Aytu BioPharma Alternatives Lisata Therapeutics Alternatives Natural Alternatives International Alternatives Dare Bioscience Alternatives Reviva Pharmaceuticals Alternatives Cadrenal Therapeutics Alternatives Elevation Oncology Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PRTG) was last updated on 8/6/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredDebt Crisis Warning: How to Protect Your Wealth Before August 31stOn August 31st, the U.S. runs out of “extraordinary measures” to avoid default—and Washington insiders are alr...American Alternative | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | SponsoredGuess Who the Gvt Could Partner With Next?The Government Just Made a $400M Bet. Who's Next? A $100 trillion wealth shift is quietly underway... and t...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Portage Biotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Portage Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PRTG Stock Alerts